The White House canceled a meeting Tuesday (July 28) with drug companies to discuss an alternative to the president’s upcoming executive order to direct Medicare to tie Part B drug reimbursement to international prices, a White House spokesperson said. It’s unclear whether or when the meeting will be rescheduled. President Donald Trump said Friday drug company executives would visit the White House Tuesday to discuss the most favored nation executive order. If drug makers come up with a suitable alternative,...